Pacific Biosciences of California, Inc. (PACB)
2.54
+0.03
(+1.20%)
USD |
NASDAQ |
Oct 02, 16:00
2.54
0.00 (0.00%)
After-Hours: 20:00
Pacific Biosciences of California Enterprise Value : 1.259B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.259B |
| October 01, 2026 | 1.249B |
| September 30, 2026 | 1.206B |
| September 29, 2026 | 1.038B |
| September 28, 2026 | 1.001B |
| September 25, 2026 | 972.73M |
| September 24, 2026 | 960.30M |
| September 23, 2026 | 907.46M |
| September 22, 2026 | 926.11M |
| September 21, 2026 | 891.92M |
| September 18, 2026 | 895.03M |
| September 17, 2026 | 898.14M |
| September 16, 2026 | 885.71M |
| September 15, 2026 | 885.71M |
| September 14, 2026 | 888.81M |
| September 11, 2026 | 873.27M |
| September 10, 2026 | 863.95M |
| September 09, 2026 | 870.17M |
| September 08, 2026 | 879.49M |
| September 04, 2026 | 888.81M |
| September 03, 2026 | 873.27M |
| September 02, 2026 | 879.49M |
| September 01, 2026 | 867.06M |
| August 31, 2026 | 890.37M |
| August 28, 2026 | 904.36M |
| Date | Value |
|---|---|
| August 27, 2026 | 950.98M |
| August 26, 2026 | 954.08M |
| August 25, 2026 | 941.65M |
| August 24, 2026 | 867.06M |
| August 21, 2026 | 888.81M |
| August 20, 2026 | 851.52M |
| August 19, 2026 | 863.95M |
| August 18, 2026 | 823.54M |
| August 17, 2026 | 845.30M |
| August 14, 2026 | 826.65M |
| August 13, 2026 | 826.65M |
| August 12, 2026 | 814.22M |
| August 11, 2026 | 823.54M |
| August 10, 2026 | 826.65M |
| August 07, 2026 | 837.53M |
| August 06, 2026 | 831.31M |
| August 05, 2026 | 873.27M |
| August 04, 2026 | 916.79M |
| August 03, 2026 | 910.57M |
| July 31, 2026 | 904.36M |
| July 30, 2026 | 929.22M |
| July 29, 2026 | 904.36M |
| July 28, 2026 | 901.25M |
| July 27, 2026 | 891.92M |
| July 24, 2026 | 891.92M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Illumina, Inc. | 42.59B |
| Danaher Corp. | 173.98B |
| Repligen Corp. | 10.13B |
| Thermo Fisher Scientific, Inc. | 280.71B |
| Agilent Technologies, Inc. | 49.50B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -44.74M |
| Revenue (Quarterly) | 39.01M |
| Total Expenses (Quarterly) | 83.75M |
| EPS Diluted (Quarterly) | -0.144 |
| Gross Profit Margin (Quarterly) | 30.26% |
| Profit Margin (Quarterly) | -114.7% |
| Earnings Yield | -16.97% |
| Normalized Earnings Yield | -15.45 |